Cost-effectiveness of the HepCATT intervention in specialist drug clinics to improve case-finding and engagement with HCV treatment for people who inject drugs in England
Uloženo v:
| Hlavní autor: | |
|---|---|
| Další autoři: | |
| Médium: | Kniha |
| Jazyk: | španělština angličtina |
| Témata: | |
| On-line přístup: | Path |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky: Cost-effectiveness of the HepCATT intervention in specialist drug clinics to improve case-finding and engagement with HCV treatment for people who inject drugs in England
- Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?
- Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial
- Measuring risk of HIV and HCV among injecting drug users in the Russian Federation
- HEP C: PRESCRIPTION FOR LIVING
- INJECTING AND SEXUAL RISK CORRELATES OF HBV AND HCV SEROPREVALENCE AMONG NEW DRUG INJECTORS
- GLOBAL ESTIMATES OF PREVALENCE OF HCV INFECTION AMONG INJECTING DRUG USERS